| scholarly article | Q13442814 |
| P50 | author | Florent Mouliere | Q41134950 |
| P2093 | author name string | M Silhol | |
| T Maurice | |||
| I Höllinger | |||
| J Meffre | |||
| L Tapia-Arancibia | |||
| S Arancibia | |||
| P433 | issue | 3 | |
| P921 | main subject | neurotoxicity | Q3338704 |
| toxic encephalopathy | Q7830379 | ||
| P304 | page(s) | 316-326 | |
| P577 | publication date | 2008-07-15 | |
| P1433 | published in | Neurobiology of Disease | Q15716606 |
| P1476 | title | Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats | |
| P478 | volume | 31 |
| Q34370099 | 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease |
| Q35622640 | 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease |
| Q49885025 | A Review on Central Nervous System Effects of Gastrodin |
| Q92192215 | A role for FNDC5/Irisin in the beneficial effects of exercise on the brain and in neurodegenerative diseases |
| Q57210218 | AAV-Syn-BDNF-EGFP Virus Construct Exerts Neuroprotective Action on the Hippocampal Neural Network during Hypoxia In Vitro |
| Q90263988 | Accelerated Ovarian Failure as a Unique Model to Study Peri-Menopause Influence on Alzheimer's Disease |
| Q50531667 | Acute Down-regulation of BDNF Signaling Does Not Replicate Exacerbated Amyloid-β Levels and Cognitive Impairment Induced by Cholinergic Basal Forebrain Lesion. |
| Q28484767 | Alzheimer's disease related markers, cellular toxicity and behavioral deficits induced six weeks after oligomeric amyloid-β peptide injection in rats |
| Q34949669 | Amyloid-beta induced CA1 pyramidal cell loss in young adult rats is alleviated by systemic treatment with FGL, a neural cell adhesion molecule-derived mimetic peptide |
| Q38953647 | Angiotensin II Receptor Blockers Attenuate Lipopolysaccharide-Induced Memory Impairment by Modulation of NF-κB-Mediated BDNF/CREB Expression and Apoptosis in Spontaneously Hypertensive Rats |
| Q52366164 | Anti-amyloidgenic and neurotrophic effects of tetrahydroxystilbene glucoside on a chronic mitochondrial dysfunction rat model induced by sodium azide. |
| Q58122610 | Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice |
| Q43099572 | Antiglycative activity of sulforaphane: a new avenue to counteract neurodegeneration? |
| Q48682952 | Associations Between ApoEε4 Carrier Status and Serum BDNF Levels--New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer's Disease |
| Q41810754 | Astrocytes mediated the nootropic and neurotrophic effects of Sarsasapogenin-AA13 via upregulating brain-derived neurotrophic factor |
| Q40857583 | Aβ25-35 Suppresses Mitochondrial Biogenesis in Primary Hippocampal Neurons |
| Q45068656 | BARHL1 Is Downregulated in Alzheimer's Disease and May Regulate Cognitive Functions through ESR1 and Multiple Pathways |
| Q58710855 | BDNF inhibits neurodegenerative disease-associated asparaginyl endopeptidase activity via phosphorylation by AKT |
| Q35168576 | BDNF repairs podocyte damage by microRNA-mediated increase of actin polymerization |
| Q34344683 | BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases |
| Q93047791 | Beneficial effects of AAV1-Rheb(S16H) administration in the adult hippocampus |
| Q38693438 | Biochemical and Radiological Markers of Alzheimer's Disease Progression |
| Q37928495 | Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond |
| Q34017880 | Brain-derived neurotrophic factor in neurodegenerative diseases |
| Q43248314 | Brain-derived neurotrophic factor inhibits phenylalanine-induced neuronal apoptosis by preventing RhoA pathway activation |
| Q34110183 | Brain-derived neurotrophic factor is associated with age-related decline in hippocampal volume |
| Q52149355 | Brain-derived neurotrophic factor mediates neuroprotection against Aβ-induced toxicity through a mechanism independent on adenosine 2A receptor activation. |
| Q37650426 | Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease |
| Q35006125 | Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration |
| Q45300839 | Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. |
| Q38925596 | Conditional Depletion of Hippocampal Brain-Derived Neurotrophic Factor Exacerbates Neuropathology in a Mouse Model of Alzheimer's Disease |
| Q37947984 | Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development. |
| Q38903903 | Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects |
| Q35999021 | Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer's disease: a meta-analysis study (N=7277). |
| Q91960810 | Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer's Disease |
| Q90024959 | Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies |
| Q42446567 | Distinct subcellular localization of BDNF transcripts in cultured hypothalamic neurons and modification by neuronal activation. |
| Q48769291 | Dysregulation of TrkB Receptors and BDNF Function by Amyloid-β Peptide is Mediated by Calpain |
| Q39529335 | ERK1/2 and ERK5 have distinct roles in the regulation of brain-derived neurotrophic factor expression. |
| Q36520298 | Electroacupuncture at the Baihui acupoint alleviates cognitive impairment and exerts neuroprotective effects by modulating the expression and processing of brain-derived neurotrophic factor in APP/PS1 transgenic mice |
| Q37534435 | Electroacupuncture decreases cognitive impairment and promotes neurogenesis in the APP/PS1 transgenic mice |
| Q38829577 | Engineered BDNF producing cells as a potential treatment for neurologic disease |
| Q41628930 | Epigenetic regulation by G9a/GLP complex ameliorates amyloid-beta 1-42 induced deficits in long-term plasticity and synaptic tagging/capture in hippocampal pyramidal neurons. |
| Q87010150 | Expression of full-length and truncated trkB in human striatum and substantia nigra neurons: implications for Parkinson's disease |
| Q38641542 | Filling the void: a role for exercise induced BDNF and brain amyloid precursor protein processing |
| Q38324150 | From microRNA target validation to therapy: lessons learned from studies on BDNF. |
| Q64967081 | Ganglioside GQ1b ameliorates cognitive impairments in an Alzheimer's disease mouse model, and causes reduction of amyloid precursor protein. |
| Q37295252 | Gene therapy in Alzheimer's disease - potential for disease modification |
| Q34368728 | Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Aβ or tau pathology |
| Q51036604 | Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients. |
| Q28538189 | Identification of BDNF sensitive electrophysiological markers of synaptic activity and their structural correlates in healthy subjects using a genetic approach utilizing the functional BDNF Val66Met polymorphism |
| Q41102430 | Impact of an additional chronic BDNF reduction on learning performance in an Alzheimer mouse model |
| Q34700226 | Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease |
| Q27318334 | In vivo AAV1 transduction with hRheb(S16H) protects hippocampal neurons by BDNF production |
| Q54957550 | Interactions Among Polymorphisms of Susceptibility Loci for Alzheimer's Disease or Depressive Disorder. |
| Q34019665 | Intranasal delivery of neurotrophic factors BDNF, CNTF, EPO, and NT-4 to the CNS. |
| Q41951765 | L-3-n-butylphthalide improves cognitive impairment of APP/PS1 mice by BDNF/TrkB/PI3K/AKT pathway |
| Q33817811 | Late-onset dementia: a mosaic of prototypical pathologies modifiable by diet and lifestyle |
| Q47663680 | Low Vs. High Alcohol: Central Benefits Vs. Detriments. |
| Q41458458 | MiR-206 decreases brain-derived neurotrophic factor levels in a transgenic mouse model of Alzheimer's disease |
| Q33639389 | Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression |
| Q48275180 | Modulating the Balance of Synaptic and Extrasynaptic NMDA Receptors Shows Positive Effects against Amyloid-β-Induced Neurotoxicity. |
| Q37776087 | Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease |
| Q38045223 | Neurodegeneration, β-amyloid and mood disorders: state of the art and future perspectives |
| Q92442452 | Neuroprotective Effect of ent-Kaur-15-en-17-al-18-oic Acid on Amyloid Beta Peptide-Induced Oxidative Apoptosis in Alzheimer's Disease |
| Q41866446 | Neuroprotective effects of LMW and HMW FGF2 against amyloid beta toxicity in primary cultured hippocampal neurons. |
| Q22252335 | New insights into brain BDNF function in normal aging and Alzheimer disease |
| Q39743698 | Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity |
| Q36467129 | Norepinephrine Protects against Amyloid-β Toxicity via TrkB. |
| Q40582623 | Nucleic Acid-Based Therapy Approaches for Huntington's Disease |
| Q34067152 | Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice |
| Q47866309 | Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer's Disease: Are There Methodological Biases? |
| Q35748709 | Phloroglucinol Attenuates the Cognitive Deficits of the 5XFAD Mouse Model of Alzheimer's Disease |
| Q37139942 | Phosphoinositide 3-kinase enhancer (PIKE) in the brain: is it simply a phosphoinositide 3-kinase/Akt enhancer? |
| Q60045409 | Physical Exercise Enhances Neuroplasticity and Delays Alzheimer's Disease |
| Q35865843 | Plasma BDNF levels associate with Pittsburgh compound B binding in the brain |
| Q38741096 | Plasma REST: a novel candidate biomarker of Alzheimer's disease is modified by psychological intervention in an at-risk population |
| Q57178494 | Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer's Disease: A Systematic Review and Meta-Analysis |
| Q38772566 | Potential for Stem Cells Therapy in Alzheimer's Disease: Do Neurotrophic Factors Play Critical Role? |
| Q26827281 | Potential therapeutic effects of neurotrophins for acute and chronic neurological diseases |
| Q36177379 | Progesterone increases the release of brain-derived neurotrophic factor from glia via progesterone receptor membrane component 1 (Pgrmc1)-dependent ERK5 signaling |
| Q37614594 | Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer's Therapy? |
| Q37314898 | Replenishment of microRNA-188-5p restores the synaptic and cognitive deficits in 5XFAD Mouse Model of Alzheimer's Disease |
| Q38345937 | Role of CREB in the regulatory action of sarsasapogenin on muscarinic M1 receptor density during cell aging |
| Q92824866 | Role of miRNAs in Alzheimer's Disease and Possible Fields of Application |
| Q58578868 | Sevoflurane Exacerbates Cognitive Impairment Induced by A in Rats through Initiating Neurotoxicity, Neuroinflammation, and Neuronal Apoptosis in Rat Hippocampus |
| Q34111160 | Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents |
| Q91609661 | Spinosin Attenuates Alzheimer's Disease-Associated Synaptic Dysfunction via Regulation of Plasmin Activity |
| Q48123194 | Standardized Herbal Formula PM012 Decreases Cognitive Impairment and Promotes Neurogenesis in the 3xTg AD Mouse Model of Alzheimer's Disease |
| Q48397223 | Synergistic effects of GSK-3β and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats |
| Q94464151 | TRP Channels as Emerging Therapeutic Targets for Neurodegenerative Diseases |
| Q36587120 | Tau-Driven Neuronal and Neurotrophic Dysfunction in a Mouse Model of Early Tauopathy. |
| Q34540937 | The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-Analysis |
| Q92257585 | The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury |
| Q61810306 | The Protective Effects of PSM-04 Against Beta Amyloid-Induced Neurotoxicity in Primary Cortical Neurons and an Animal Model of Alzheimer's Disease |
| Q94502594 | The Regulation of microRNAs in Alzheimer's Disease |
| Q58558248 | The Role of Irisin in Alzheimer's Disease |
| Q34556534 | The effect of acute exercise on blood concentrations of brain-derived neurotrophic factor in healthy adults: a meta-analysis |
| Q90448209 | The effects of PPAR-γ agonist pioglitazone on hippocampal cytokines, brain-derived neurotrophic factor, memory impairment, and oxidative stress status in lipopolysaccharide-treated rats |
| Q37728184 | The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice |
| Q91757332 | Therapeutic exercise accompanied by neuronal modulation to enhance neurotrophic factors in the brain with central nervous system disorders |
| Q42045019 | Time-course and regional analyses of the physiopathological changes induced after cerebral injection of an amyloid β fragment in rats |
| Q40311429 | TrkB activation by 7, 8-dihydroxyflavone increases synapse AMPA subunits and ameliorates spatial memory deficits in a mouse model of Alzheimer's disease |
| Q98386132 | TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer's disease pathologies |
| Q38106649 | TrkB receptor signalling: implications in neurodegenerative, psychiatric and proliferative disorders. |
| Q35753185 | TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice |
| Q61803793 | TrkB-ICD Fragment, Originating From BDNF Receptor Cleavage, Is Translocated to Cell Nucleus and Phosphorylates Nuclear and Axonal Proteins |
| Q90433673 | Upregulation of Neuronal Rheb(S16H) for Hippocampal Protection in the Adult Brain |
| Q48031501 | Val66Met Polymorphism in BDNF Has No Sexual and APOE ε4 Status-Based Dimorphic Effects on Susceptibility to Alzheimer's Disease: Evidence From an Updated Meta-Analysis of Case-Control Studies and High-Throughput Genotyping Cohorts |
Search more.